HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
59,500
-1,500 (-2.46%)
At close: Apr 28, 2026

HEM Pharma Revenue

In the year 2025, HEM Pharma had annual revenue of 12.98B KRW, down -13.86%. HEM Pharma had revenue of 3.67B in the quarter ending December 31, 2025, a decrease of -41.93%.

Revenue
12.98B
Revenue Growth
-13.86%
P/S Ratio
32.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
426.98B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.98B-2.09B-13.86%
Dec 31, 202415.07B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition